Ultragenyx Pharmaceutical Inc. buy Stifel Nicolaus
Start price
31.05.24
/
50%
€37.00
Target price
31.05.25
€116.79
Performance (%)
32.43%
Price
03.10.24
€49.00
Summary
This prediction is currently active. The BUY prediction by Stifel_Nicolaus for Ultragenyx Pharmaceutical Inc. has seen massive gains of 32.43%. This prediction currently runs until 31.05.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 1.240% | 1.240% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Stifel_Nicolaus for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Stifel Nicolaus from $124.00 to $127.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat